References

  1. Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J, Guth AA. Breast Cancer in Young Women. J Am Coll Surg. 2008; 206 (6): 1193-1203 . This article on PubMed

  2. Lamy P-J, Romieu G, Rouanet P, Jacot W. Classification moléculaire des cancers du sein : utilité en clinique. Médecine Nucléaire. 2010; 34:32-43

  3. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer Breast. Breast Cancer Res Treat. 2008 Feb;107(3):309-30. This article on Pubmed Central

  4. Perou CM, Sorlie T, Elisen MB, Van de Rijn M, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumours. Nature. 2000; 406: 747-52. This article on PubMed

  5. Sorlie T, Tibshirani R, Parker J, Hastie T et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23

  6. van 't Veer LJ, Dai H, van de Vijver MJ, He YD et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002 Jan 31;415(6871):530-6. This article on PubMed

  7. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10393-8. This article on Pubmed Central

  8. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96. This article on PubMed

  9. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama. 2006; 295:2492-2502. This article on PubMed

  10. Cheang, Chia S K, Voduc D, Gao D, Leung S, Snider J et al. Ki-67 Index, Her2 status, and prognosis of patients with luminal B breast cancer. J Nat Cancer Inst. 2009; 101: 736-750. This article on PubMed

  11. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004 Aug 15;10(16):5367-74. This article on PubMed

  12. Blows FM, Driver KE, Schmidt MK et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010; 7: e1000279. This article on PubMed

  13. Hugh J, Hanson J, Cheang MC, Nielsen TO, Perou CM et al. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 Trial. J Clin Oncol. 2009 Mar 10;27(8):1168-76. This article on Pubmed Central

  14. Tavassoli FA, Devilee P, Eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs Lyon: IARC Press. 2004

  15. Elston CW, Ellis JO. Pathological prognostic factors in breast cancer I- the values of histological grade in breast cancer: experience from a long study with long term follow up. Histopathology. 1991; 19:403-410 . This article on PubMed

  16. Antonio C Wolff, M Elizabeth, H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Journal of Clinical Oncology. 2007; 25 :118-145. This article on PubMed

  17. Abalkail AA, Zahawi HM, Almasri NM, Hameed OK. The role of young population structure in determining age distribution of breast cancer in Jordan. J Bahrain Med Society. 2003; 15: 28-33

  18. Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ et al. Molecular Breast Cancer Subtypes in Premenopausal and Postmenopausal African-American Women: Age-Specific Prevalence and Survival. J Surg Res. 2007 Nov;143(1):109-18. This article on PubMed

  19. Bhargava R, Striebel J, Beriwal S, Flickinger JC, Onisko A, Ahrendt G et al. Prevalence, Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers. Int J Clin Exp Pathol. 2009; 2(5):444-55. This article on PubMed

  20. Junichi K, Takoya M, Takanori I, Hisahi H, Masafumi K, Futoshi A et al. the prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. The Breast. 2007; 16: S72-S77. This article on PubMed

  21. Al Tamimi DM, Shawarby MA, Ahmed A, Hassan AK, AlOdaini AA. Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study. BMC Cancer. 2010;10:223. This article on PubMed

  22. Belkacémi Y, Penault-Llorca F, Gligorov J, Azria D. Intérêt des classifications moléculaires pour prédire la rechute locale et la diffusion métastatique des cancers du sein. Cancer/Radiothérapie. 2008; 12:577-583

  23. Tabar L, Vitak B, Chen HH, Prevost TC, Duffy SW. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results. Swiss Surg. 1999;5(5):199-204. This article on PubMed